Join a Legacy of Innovation 110 Years and Counting!

　　Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

　　Summary

　　The Director is responsible for executing Oncology focused transactions in support of prospective Business Development initiatives. These initiatives will include, but not be limited to, product or Company acquisitions, in/out-licensing activities, strategic co-commercialization/ co-development transactions, Option deals, R&D collaborations, ARO collaborations, CDx transactions or other structures as needed. The Director will be a key member of the deal team as assigned by the VP, Global BD and may be asked to lead required diligence, term sheet development or negotiation of definitive agreements. The Director will consult with US and Tokyo Global Finance to align on assumptions embedded in the financial analyses. Required metrics may include raNPV/NPV, raIRR/IRR, NPV Break-Even modeling, Comparables analysis, sensitivity analyses of key variables (POS, COGS, GTN etc.) and other relevant metrics as assigned or indicated. The Director may be asked by the VP of Global BD to provide strategic fit and commercial assessments in the form of "Litmus" tests and/or to carry out Oncology/Other therapeutic area market research activities. The position is also responsible for providing training and development to junior members of the team as appropriate. Participation on inter-functional teams is an important aspect of this position.

　　Responsibilities

　　Deal Team ParticipationAct as an integral member of the transaction deal team

　　Act as a Transaction Manager – interface with Tokyo BD and DSE (or ASCA) as needed

　　Manage flow of information among regions and key internal stakeholderso Sharing of Target provided informationo Global BD generated Analyses – Litmus, market research, financials, diligence materialso Coordinate integration of Territorial P&Ls into Global P&L in concert with Finance

　　Respond to Q&A from Finance, Tokyo BD, Oncology Business Group, CE and other key stakeholders

　　As assigned, act as the Deal Lead, conduct necessary functional area DD and be responsible for completion of the DD Summary Deck including an in depth knowledge of key answered and unanswered questions for each discipline

　　Provide Business Analytics for specific deals

　　Comparables Analysis based on Deal type (ADC, Small Molecule, Oncology or other therapeutic area)

　　Assess and recommend partners most appropriate to support our Strategic Initiatives

　　Vet each opportunity for consistency with established Portfolio Strategy

　　Lead development of B-E analyses by assembling required inputs – COGS, CDP (Spending, Timing), LOE, S&M expense

　　Conduct situational analyses and make pro-con and risk-reward trade off recommendations to senior management including but not limited to LCM opportunities, divestitures, and acquisitions, and lead related transactions for DSI informed by the individual’s significant transaction and financial experience

　　Cancer Enterprise (CE) Strategy DevelopmentIn concert with CE leadership, support CE in its ongoing development of the Alpha and ADC Strategies.

　　Assure functional excellence by training and development of more junior staff and Direct Report(s) in the appropriate methods of business analysis. Actively evolve training with industry and discipline trends to assure Daiichi Sankyo has knowledge of and access to “best in class” tools and methodologies.

　　Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.

　　Education Qualifications (from an accredited College or University)

　　Bachelor's Degree in business or finance related discipline required

　　Master's Degree in Business, Finance, Management or JD preferred

　　Experience Qualifications

　　4 + years of experience in life science business development and/or a corporate finance/financial analysis role within the pharmaceutical industry required

　　4 + years of significant prior contract negotiation & deal experience (e.g., M&A, In-Licensing, Strategic Partnerships) required

　　4+ years of significant lead negotiator role experience preferred

　　Travel

　　Ability to travel up to 20% Travel as required by deal process requirementsDaiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.

　　At the heart of Daiichi Sankyo, Inc. is the fundamental belief that each employee helps shape our success. We have created an exceptional working environment that values and rewards individual contributions, but we also believe in the power of collaboration. We provide employees with the training, tools and technology that they need to excel. Our open communication, emphasis on results, and spirit of personal accountability are hallmarks of our corporate culture and ensures that each employee’s unique abilities are valued and utilized. We invite you to consider a career at Daiichi Sankyo, Inc.